Music therapy impact during anaesthesia for gastrointestinal endoscopy

ISRCTN ISRCTN13545435
DOI https://doi.org/10.1186/ISRCTN13545435
Secondary identifying numbers 23-15
Submission date
31/10/2025
Registration date
03/11/2025
Last edited
31/10/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Ambulatory gastrointestinal (GI) endoscopy constitutes a large and growing share of procedural care. Anxiety correlates with fears about anaesthesia, pain, and adverse outcomes, and when not controlled, higher doses of hypnotics and analgesics are typically required. Music has long been integrated into medical practice and, in modern trials, has demonstrated clinically relevant benefits. Across adult surgical settings, music interventions reduce anxiety and improve pain outcomes when compared with usual care or silence. This study aims to find out whether patient‑selected music reduces propofol requirements during combined upper and lower gastrointestinal endoscopy.

Who can participate?
Outpatients aged 18 years and over scheduled for diagnostic gastroscopy and colonoscopy

What does the study involve?
Patients are randomly allocated to patient-selected music plus standard care or to standard care alone.

What are the possible benefits and risks of participating?
Benefits: reduced anxiety and propofol consumption
Risks: no additional risks, same as standard of care

Where is the study run from?
Princess Grace Hospital Center (Monaco)

When is the study starting and how long is it expected to run for?
November 2023 to October 2025

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
1. Dr Gildas Rousseau, gildas.rousseau@chpg.mc
2. Nicolas Rijo, recherche.clinique@chpg.mc
3. Dr Sorina-Dana Mihailescu, recherche.clinique@chpg.mc

Contact information

Dr Gildas Rousseau
Public, Scientific, Principal investigator

Centre Hospitalier Princesse Grace
Service d'anesthésie réanimation
1 avenue Pasteur
Monaco
98000
Monaco

Phone +377 (0)97989900
Email gildas.rousseau@chpg.mc

Study information

Study designOpen‑label single‑centre randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titlePatient‑selected music reduces propofol requirements during combined upper and lower gastrointestinal endoscopy: a randomized controlled trial
Study acronymMUSICENDO
Study objectivesMusic interventions can decrease sedative requirements and can reduce perioperative anxiety
Ethics approval(s)Ethics approval not required
Health condition(s) or problem(s) studiedAnxiety during gastroscopy and colonoscopy
InterventionThis is an open‑label, single‑centre, randomized, controlled trial conducted at Princess Grace Hospital, Monaco. Consecutive adult outpatients scheduled for diagnostic gastroscopy and colonoscopy will be screened. Patients are allocated 1:1 to patient‑selected music plus standard care or to standard care alone using a computer-generated schedule with fixed permuted blocks.
Intervention typeOther
Primary outcome measurePropofol consumption rate (mg·kg⁻¹·min⁻¹), defined as total propofol administered divided by body weight and by the intervention length (minutes from induction to procedure end)
Secondary outcome measures1. Procedure duration (minutes), from induction to end of procedure
2. Total ambulatory pathway time (minutes), from induction to return to ambulatory unit
3. Anxiety level measured using the Amsterdam Preoperative Anxiety and Information Scale (APAIS) score at preanaesthesia consultation and on arrival in the ambulatory unit
4. Haemodynamic changes (systolic and diastolic blood pressures and pulse pressure) before vs after procedure
5. Adverse events (e.g., bronchospasm, laryngospasm) recorded during procedure
6. Number of propofol vials used per case for the procedure
Overall study start date07/11/2023
Completion date06/10/2025

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target number of participants88
Total final enrolment89
Key inclusion criteriaAdults with ASA physical status I–III planned for combined diagnostic upper and lower GI endoscopy in ambulatory care
Key exclusion criteria1. Legal incapacity
2. Hospital stay >24 h
3. Psychiatric disorders
4. Alcohol or toxic substance use
5. Severe renal failure (creatinine clearance <30 mL·min⁻¹)
6. Pregnancy or breastfeeding
7. Significant hearing impairment precluding music exposure
8. Urgent procedures
9. Lack of social insurance
Date of first enrolment20/03/2024
Date of final enrolment16/07/2024

Locations

Countries of recruitment

  • Monaco

Study participating centre

Centre Hospitalier Princesse Grace
1 avenue Pasteur
Monaco
98000
Monaco

Sponsor information

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date31/12/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planData will be shared with researchers who submit a methodologically sound protocol to Gildas Rousseau (gildas.rousseau@chpg.mc) following the signing of a data access agreement.

Editorial Notes

31/10/2025: Study's existence confirmed by the Princess Grace Hospital Centre.